Skip to main content

Microbiologics Licenses Biomatrica Technology for Molecular Controls

NEW YORK (GenomeWeb) – Microbiologics today announced it has licensed Biomatrica's technology for use in its molecular controls for rapid diagnostic instruments and assays.

The deal covers Biomatrica's DNAstable and RNAstable reagents for stabilizing DNA and RNA standards, and combines the firms' biomaterial development expertise and preservation know-how "to create highly stable biological controls that may be globally delivered without cold-chain requirements," the firms said in a statement.

The first Microbiologics product to be stabilized using Biomatrica's technology is the recently launched Helix Elite Molecular Standards, which includes synthetic RNA and DNA sequences as amplification controls in clinical assays.

Microbiologics VP of Molecular Products and Services Brian Beck noted that combining Biomatrica's DNA and RNA stabilizers with Microbiologics' molecular standards improves storage convenience and reliability of the products, leading to lower costs to customers.

Financial and other terms of the deal were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.